Day: September 18, 2020

Attached is information regarding a transaction between financially connected parties of a primary insider.Attachments201809 Mánaþing ehf – Kaup201809 Sólþing ehf – Sala

Attached is information regarding transactions of board members and senior managers, along with their financially connected parties, in Icelandair Group‘s share offering.Attachments201709 Akurrif – Kaup201709 Brekkumýri – Kaup201709 John F Thomas – Kaup201709 Mánaþing – Kaup201709 Möskvi – Kaup201709 Náttúlfur ehf – Kaup201709 Svafa Grönfeldt – Kaup201709 Viðunandi ehf – Kaup2009017 EFIA -Kaup2009017 Hvarhylur – Kaup2009017 Jú ehf – Kaup2009017 Skeljungur – Kaup201709 Ting ehf – Kaup2009017 Hermann Árnason – Kaup

BUFORD, Georgia, Sept. 17, 2020 (GLOBE NEWSWIRE) — OneWater Marine Inc. (NASDAQ: ONEW) (“OneWater” or the “Company”) announced today the pricing of an underwritten public offering of 3,170,868 shares of its Class A common stock, par value $0.01 per share (“Class A common stock”), at $20.00 per share. The Company is offering 425,000 shares of its Class A common stock, and the selling stockholders named in the registration statement on Form S-1 (the “registration statement”) previously filed with the Securities and Exchange Commission (the “SEC”) are offering 2,745,868 shares of OneWater’s Class A common stock. In addition, an affiliate of Goldman Sachs & Co. LLC has granted the underwriters a 30-day option to purchase up to an additional 475,630 shares of OneWater’s Class A common stock. The offering is expected to close on...

Three complete responses (complete disappearance of all lesions) reported: two in 2nd line head and neck squamous cell carcinoma (HNSCC) and one in 1st line non-small cell lung cancer (NSCLC)Five responses in patients (both indications) with negative (< 1%) or moderate PD-L1 expression where pembrolizumab monotherapy does not work wellMedian Progression Free Survival (PFS) of 4.3 months in HNSCC patients and 47% progression free at 6 months in this very aggressive late stage diseasePFS continues to improve in 1st line NSCLC patients with median PFS of 11.8 months and patients with responses have durable onesSYDNEY, Australia, Sept. 18, 2020 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) announces new interim data from its ongoing Phase II TACTI-002 study. The data was presented in two poster presentations at the ESMO...

SEATTLE, Sept. 17, 2020 (GLOBE NEWSWIRE) — Athira Pharma, Inc., (Nasdaq: ATHA) (“Athira”), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration, today announced the pricing of its initial public offering of 12,000,000 shares of its common stock at a price to the public of $17.00 per share. All of the shares of common stock are being offered by Athira. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Athira, are expected to be $204.0 million. Athira’s common stock is expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “ATHA” on September 18, 2020. The offering is expected to close on September 22, 2020, subject to satisfaction of...

Icelandair Group’s public offering ended at 16:00 on 17 September 2020. In the offering ISK 20 billion new shares were offered for sale. The offering was oversubscribed by 85% with strong demand from both institutional and retail investors. The offering price was fixed in both order books at ISK 1.0 per share.Total subscriptions were over 9 thousand and amounted to ISK 37.3 billion.The Company’s Board of Directors decided to accept subscriptions amounting to ISK 30.3 billion and to increase the offering size to a total of ISK 23 billion shares.Total allocated warrants, amounting to 25% of 23 billion, come to ISK 5.75 billion shares.Allocation was in line with the terms of the offering.Existing shareholders who participated in the offering received full allotment in line with their existing stake.Subscriptions from around 1,000 employees...

TORTOLA, British Virgin Islands, Sept. 17, 2020 (GLOBE NEWSWIRE) — Orca Energy Group Inc. (“Orca” or the “Company”) (TSX-V: ORC.A, ORC.B) today announced that its Board of Directors has declared a quarterly cash dividend of $0.08 (Cdn) per Class A Common Voting Share of the Company and $0.08 (Cdn) per Class B Subordinate Voting Share (“Class B Shares“) of the Company. The dividend will be payable on October 15, 2020 to holders of Class A Common Voting Shares and Class B Shares of record on September 30, 2020.Approval of Resolutions at Annual Meeting of ShareholdersOrca is pleased to announce that its shareholders approved all resolutions at its annual meeting of shareholders held on September 17, 2020 as follows:Resolution to fix the number of directors to be elected at the meeting at four (4), with 99.32% of shares...